Jenkins: OND sometimes more conservative on safety than OSE:

08/18/2008 | TheRPMReport.com

John Jenkins, director of the Office of New Drugs, says, "There's the perception in the outside world that OND is always overruling OSE [Office of Surveillance & Epidemiology] in a way that may be viewed as less focused on safety. But there are cases where the OND perspective is more conservative on the safety issue than the feedback we're getting from our OSE colleagues."

View Full Article in:

TheRPMReport.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR